Halozyme Therapeutics | HALO - DEUDA





DEUDA Cambio Fecha
Acadia Pharmaceuticals USD 50.79M 1.39M 2026-03
Agios Pharmaceuticals USD 35.74M 4.46M 2026-03
Alnylam Pharmaceuticals USD 1.27B 5.33M 2026-03
Amarin USD 0 0 2025-03
Amgen USD 57.32B 2.72B 2026-03
Baxter International USD 9.69B 93M 2026-03
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 1.29B 4.48M 2026-03
DBV Technologies USD 6.1M 2.49M 2026-03
Eli Lilly USD 43.37B 867M 2026-03
Halozyme Therapeutics USD 2.14B 2.01M 2026-03
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 1.91B 425.5M 2026-06
MannKind USD 330.96M 36.48M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 0 0 2022-06
Pfizer USD 63.19B 536M 2026-06
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12